Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price target increased by research analysts at The Goldman Sachs Group from $9.00 to $10.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 1.63% […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price target increased by research analysts at The Goldman Sachs Group from $9.00 to $10.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 1.63% […]
